New York Oncology Hematology PC - Amsterdam — Amsterdam, New York

New York Oncology Hematology PC - Amsterdam is a clinical research site located in Amsterdam, New York, United States 12010.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

New York Oncology Hematology PC - Amsterdam has participated in 12 clinical trials with 4 currently active.

Therapeutic areas: Breast Cancer, Melanoma of Unknown Primary, Recurrent Melanoma.

Sponsors: NSABP Foundation Inc, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Amsterdam

Browse all research sites in New York · View every site in Amsterdam

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology PC - Amsterdam?

New York Oncology Hematology PC - Amsterdam has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology PC - Amsterdam conducted?

New York Oncology Hematology PC - Amsterdam has 12 clinical trials on record, with 4 currently active. Their work covers Breast Cancer, Melanoma of Unknown Primary, Recurrent Melanoma.

Is New York Oncology Hematology PC - Amsterdam accredited by Crixeo Clinical Trials?

New York Oncology Hematology PC - Amsterdam has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology Hematology PC - Amsterdam?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.